Summary
Bridge Biotherapeutics Inc
Founded in 2015
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Bridge Biotherapeutics Inc was founded, the company has grown faster than the industry average
Weaknesses
- Bridge Biotherapeutics Inc has a very small market share in their industry
- Variance of revenue growth is more than the industry average
Annual Revenue
Bridge Biotherapeutics Inc's annual revenue
$6692000
Based on Kona Equity data
-
Revenue per employee
$304181
-
Variance of revenue growth
0.63
-
Annual revenue growth since founding
$743555
-
Revenue growth rate from first known quarter to current
561.1%
Employee Count
22 employees
-
Employee growth rate from first known quarter to current
540.0%
Executives
Sang-Uk Kang
Senior VP, Research & Development
s**@bridgebiorx.comDeborah Kim
Med- Chem and CMC Director
d**@bridgebiorx.comMikyoung Chang
Director, Scientific Affairs and Scientific Liaison
m**@bridgebiorx.comJehrod Brenneman
Senior Director, Medicinal Chemistry
j**@bridgebiorx.comSungchan Jeong
Senior Director
s**@bridgebiorx.comNaeun Jeon
Clinical Trial Leader
n**@bridgebiorx.comLeila Revollo
Scientist I
l**@bridgebiorx.comPavel Printsev
Director, Business Development
p**@bridgebiorx.comYounhee Jung
Manager, Prc Research
y**@bridgebiorx.comChris Kim
Executive Vice President
c**@bridgebiorx.comPeter Park
Director, Finance & Operations
p**@bridgebiorx.comKim Soomin
Manager
k**@bridgebiorx.comAngela Yum
Clinical Development Strategy Head
a**@bridgebiorx.comJeong-Min Chun
Head Senior Director, Clinical Operations
j**@bridgebiorx.comKim Chulwon
Director, Research
k**@bridgebiorx.comJoengbin Ahn
Director, Communications
j**@bridgebiorx.comJin Lim
Senior Director, Strategy
j**@bridgebiorx.comJimmy Jin
Head of Discovery Biology
j**@bridgebiorx.comZieun Chang
Manager, Prc Research
z**@bridgebiorx.comLee Gwanghee
Head Vice President, Translational Research
l**@bridgebiorx.comKyungah Kim
Manager
k**@bridgebiorx.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Allinaire Therapeutics LLC
allinaire.com- Founded in 2015
- Location: Cleveland, OH
- Annual Revenue: $1.6M
- Employees: 7
- Breakthrough Medicine Learn More
Aqualung Therapeutics
aqualungtherapeutics.com- Founded in 2010
- Location: Chicago, IL
- Annual Revenue: $1.3M
- Employees: 6
- Aqualung Therapeutics Corp. is an early stage biotech company developing a therapeutic antibody to reduce inflammation in acute and chronic lung diseases. Aqualung Therapeutics (ALT) is developing multi-pronged strategies to address the development of ...
EffectorBio
effectorbio.com- Founded in 2016
- Location: Davis, CA
- Annual Revenue: $886.0K
- Employees: 6
kddsystems.com
kddsystems.com- Location: New York, NY
- Annual Revenue: $1.8M
- Employees: 20
Organoid Research Group
organoidresearch.com- Founded in 2018
- Location: Cambridge, MA
- Annual Revenue: $2.0M
- Employees: 9
- The Organoid Research Group is an online resource for scientists with an interest in oncology drug development. The OrganoidResearch.com website provides access to current news, events, and publications, and serves as a platform to exchange knowledge a...
Koutif Therapeutics
koutiftherapeutics.com- Founded in 2017
- Location: Cleveland, OH
- Annual Revenue: $957.0K
- Employees: 6
- Koutif Therapeutics aims to develop therapeutic compounds that inhibit the inflammatory cascade in a unique manner. Our medicinal chemistry strategy is based upon discoveries by Rama Mallampalli, MD and Beibei Chen, PhD on inhibitors of the ubiquitin d...
Key Information
- Name: Bridge Biotherapeutics Inc
- Category: Biotechnology
- Industry: Corporate office
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Houston Small Corporate office in Houston Mid-size Corporate office in Houston Biotechnology in Houston Small Biotechnology in Houston Mid-size Biotechnology in Houston
-
By State TX Small companies in TX Biotechnology in TX Small Biotechnology in TX Mid-size Biotechnology in TX Small Corporate office in TX Mid-size Corporate office in TX
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Corporate office Small Corporate office Mid-size Corporate office Biotechnology and Corporate office
-
Firmographic data G Score of 4 Founded in 2015 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Pharmaceuticals #Healthcare #Biotechnology #Drug Manufacturing & Research
Frequently Asked Questions
Bridge Biotherapeutics Inc's headquarters are located at 2450 Holcombe Blvd. Houston, TX 77021.
Bridge Biotherapeutics Inc's official website is bridgebiorx.com
Bridge Biotherapeutics Inc's annual revenue is $6.7 M.
Bridge Biotherapeutics Inc's SIC: 2834; 283
Bridge Biotherapeutics Inc's NAICS: 32541; 3254.
Bridge Biotherapeutics Inc has 22 employees
Bridge Biotherapeutics Inc is in the industry of Biotechnology.
